Skip to main content

LIMS platform proves popular with R&D organisations

A growing number of R&D organisations including Biogen Idec, the Penn State College of Medicine, and the Universities of Pennsylvania, Virginia and Glasgow are using Genologic’s OMIX LIMS software for translational medicine.

Richard Rauscher, director of information technology for Penn State Cancer Institute, commented: ‘It was crucial for us to choose a solution we can implement quickly across multiple labs, with immediate benefits. These systems will assist us in becoming an NCI-designated Cancer Centre, while enabling our longer term translational medicine vision.’

OMIX is a LIMS platform optimised for life sciences applications, and is scalable across multiple labs with a common underlying architecture and user interface. It can easily be coupled with Genologic’s Geneus and Proteus genomics and proteomics software.


Media Partners